These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 18762220)

  • 81. The Bordetella type III secretion system: its application to vaccine development.
    Abe A; Nagamatsu K; Watanabe M
    Microbiol Immunol; 2008 Feb; 52(2):128-33. PubMed ID: 18380810
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Complete genome sequence of Bordetella pertussis CS, a Chinese pertussis vaccine strain.
    Zhang S; Xu Y; Zhou Z; Wang S; Yang R; Wang J; Wang L
    J Bacteriol; 2011 Aug; 193(15):4017-8. PubMed ID: 21622744
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Changes of the Swedish Bordetella pertussis population in incidence peaks during an acellular pertussis vaccine period between 1997 and 2004.
    Advani A; Donnelly D; Gustafsson L; Hallander HO
    APMIS; 2007 Apr; 115(4):299-310. PubMed ID: 17504296
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Investigation of an aerosol challenge model as alternative to the intracerebral mouse protection test for potency assay of whole cell pertussis vaccines.
    Canthaboo C; Xing D; Douglas A; Corbel M
    Biologicals; 2000 Dec; 28(4):241-6. PubMed ID: 11237360
    [TBL] [Abstract][Full Text] [Related]  

  • 85. An investigation into the cause of the 1983 whooping cough epidemic in the Netherlands.
    van Gent M; de Greeff SC; van der Heide HG; Mooi FR
    Vaccine; 2009 Mar; 27(13):1898-903. PubMed ID: 19368769
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The rise in pertussis cases urges replacement of chemically-inactivated with genetically-inactivated toxoid for DTP.
    Robbins JB; Schneerson R; Keith JM; Shiloach J; Miller M; Trollors B
    Vaccine; 2007 Apr; 25(15):2811-6. PubMed ID: 17291636
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Performance of Bordetella pertussis IS481 real-time PCR in a vaccine trial setting.
    Gullsby K; Hallander HO; Bondeson K
    APMIS; 2007 Dec; 115(12):1370-5. PubMed ID: 18184407
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Manufacture of a Stable Lyophilized Formulation of the Live Attenuated Pertussis Vaccine BPZE1.
    Thalen M; Debrie AS; Coutte L; Raze D; Solovay K; Rubin K; Mielcarek N; Locht C
    Vaccines (Basel); 2020 Sep; 8(3):. PubMed ID: 32933132
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Bbvac: A Live Vaccine Candidate That Provides Long-Lasting Anamnestic and Th17-Mediated Immunity against the Three Classical
    Gestal MC; Howard LK; Dewan KK; Harvill ET
    mSphere; 2022 Feb; 7(1):e0089221. PubMed ID: 35196124
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Outer membrane vesicles as acellular vaccine against pertussis.
    Roberts R; Moreno G; Bottero D; Gaillard ME; Fingermann M; Graieb A; Rumbo M; Hozbor D
    Vaccine; 2008 Aug; 26(36):4639-46. PubMed ID: 18640169
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Molecular typing of the strains of Bordetella pertussis circulating in St. Petersburg during an outbreak of the disease].
    Kurova NN; Tseneva GIa; Vasil'eva VI; Zveriakina NN; Liamina VP; Loseva LV; Chuprynina RP
    Mol Gen Mikrobiol Virusol; 2006; (4):13-5. PubMed ID: 17094652
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Genetic stability determinants of temperature sensitive, live attenuated respiratory syncytial virus vaccine candidates.
    Lin YH; Deatly AM; Chen W; Miller LZ; Lerch R; Sidhu MS; Udem SA; Randolph VB
    Virus Res; 2006 Jan; 115(1):9-15. PubMed ID: 16099066
    [TBL] [Abstract][Full Text] [Related]  

  • 93. How Genomics Is Changing What We Know About the Evolution and Genome of Bordetella pertussis.
    Ring N; Abrahams JS; Bagby S; Preston A; MacArthur I
    Adv Exp Med Biol; 2019; 1183():1-17. PubMed ID: 31321755
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Development of a droplet digital PCR for pertussis toxin locus copy number determination in a genetically-modified Bordetella pertussis strain.
    Esson R; Falque S; Abachin E; George S; Nougarede N
    Biologicals; 2023 May; 82():101683. PubMed ID: 37149976
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Accumulation of the bvg- Bordetella pertussis a virulent mutants in the process of experimental whooping cough in mice].
    Medkova AIu; Siniashina LN; Rumiantseva IuP; Voronina OL; Kunda MS; Karataev GI
    Mol Gen Mikrobiol Virusol; 2013; (4):22-6. PubMed ID: 24645274
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Analysis of Swedish Bordetella pertussis isolates with three typing methods: characterization of an epidemic lineage.
    Advani A; Van der Heide HG; Hallander HO; Mooi FR
    J Microbiol Methods; 2009 Sep; 78(3):297-301. PubMed ID: 19577594
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Pertussis: review of epidemiology, diagnosis, management and prevention.
    Wood N; McIntyre P
    Paediatr Respir Rev; 2008 Sep; 9(3):201-11; quiz 211-2. PubMed ID: 18694712
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Is there a potential for novel, nasal pertussis vaccines?
    Locht C
    Expert Rev Vaccines; 2021 Apr; 20(4):415-423. PubMed ID: 33667341
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Better colonisation of newly emerged Bordetella pertussis in the co-infection mouse model study.
    Safarchi A; Octavia S; Luu LD; Tay CY; Sintchenko V; Wood N; Marshall H; McIntyre P; Lan R
    Vaccine; 2016 Jul; 34(34):3967-71. PubMed ID: 27346304
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Variability in derivative strains of Bordetella pertussis.
    Parker CD; Doyle S; Field LH; Hewlett E
    Dev Biol Stand; 1980; 45():119-27. PubMed ID: 6249689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.